Global Rabies Treatment Market 2016 – 2023: Industry Size, Share, Growth, Trends and Forecast
"The
Latest Research Report Rabies Treatment Market - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2023
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Rabies Treatment Market: Snapshot
The
global rabies treatment market is anticipated to gain momentum in
growth with three key factors driving the demand in the industry. The
application of novel culture media to produce contamination-free
vaccines and stringent regulatory examinations conducted by
governments could be first on the list of important market drivers.
There is a need to eliminate the risk of vaccine contamination due to
the involvement of human components and bovine spongiform
encephalopathy (BSE) agents in cultural formulations. In this regard,
manufacturers are focusing on the development of novel media for
vaccine production that are free from human and animal components.
Get
Sample Copy of this report @
https://www.marketresearchreports.biz/sample/sample/1353555
The
emerging regions of the world are expected to be the major sources of
rabies on account of the lack of active rabies vaccination programs
and rising population of stray dogs. Exposure to rabid dogs is
studied to cause a 99.0% of rabies-related deaths and 90.0% of all
rabies cases, according to the Centers for Disease Control and
Prevention (CDC). As a result, the need for anti-rabies treatment
regimens such as rabies immunoglobulin (RIG) and cell culture vaccine
(CCV) for post-exposure prophylaxis is considerably high. This could
likely increase the demand in the global rabies treatment market.
However,
the expensive cost of CCV for intramuscular administration is
foretold to stunt its adoption and that of similar vaccines.
Nonetheless, in order to withstand this issue, WHO recommends the
intradermal administration of CCV, especially in regions where
intramuscular biological is unaffordable and unavailable and rabies
is extremely prevalent.
Rabies
is a zoonotic viral disease caused due to animal bits. The disease is
known to affect domestic as well as wild animals such as bats,
skunks, foxes, ferrets, raccoons, cats, or dogs, and infects humans
upon contact with saliva of infected animal. Rabies is known to have
an incubation period of one to three months. Individuals suffering
from rabies show initial symptoms of fever and pain or tingling or
burning sensation also called as paraesthesia at the wound site. As
the disease progresses through the central nervous system (CNS),
patients exhibit hyperactivity, excited behavior, hydrophobia. Rabies
can also be paralytic and accounts for approximately 3% of all rabies
cases globally according to World Health Organization (WHO). This
form is usually misdiagnosed and has slower progression. Muscles near
the wound site begin to paralyze; untreated infections lead to coma
and cause death.
View
Report @
https://www.marketresearchreports.biz/reports/1353555/rabies-treatment-global-industry-market-research-reports
WHO
statistics also show that although rabies is prevalent in all
continents except Antarctica, more than 95% of the mortalities occur
in African and Asian countries. Rabies infections are common in areas
where human-animal interaction is more and no proper medical
treatment facility is available for treatment. In the U.S. only 55
cases have been identified since 1955 according to Centers for
Disease Control and Prevention (CDC). Rapid diagnostic tests are
available for diagnosis of rabies. These tests are usually Enzyme
Linked Immunosorbent Assay (ELISA) or fluorescent assay technology.
Synbiotics Corporation, O.K. SERVIS BioPro, s.r.o., Bio-Rad
Laboratories, Inc. and Alpha Diagnostic International are some of the
players manufacturing diagnostic kits for rabies.
Novartis
and Sanofi are key players in the global rabies treatment market.
These companies manufacture prophylactic vaccines for humans.
Sanofi’s Imovax Rabies is a human diploid cell vaccine; while
Novartis’s RabAvert is a Purified chick embryo cell vaccine.
Vaccines are also available for preventing infections in animals.
Merial a Sanofi company announced in July 2014 had it has launched
PUREVAX Feline Rabies 3 YR vaccine. This is a non-adjuvanted rabies
vaccine and provides 3 year immunity. The vaccine has been
recommended for immunization of healthy cats 12 weeks and older.
Cadila Pharmaceuticals Ltd, is also working on development of new
generation rabies vaccine in India. Under-developed countries have
initiated mass vaccination of stray dogs to control mortalities.
According to an article published by World Health Organization (WHO)
in 2014, Kenya launched a nationwide program for vaccination of dogs.
Currently, more than 3,000 dogs in Makueni County have been
vaccinated. In September 2014, The Philippines Department of
Agriculture (DA), the Australian Government and the World
Organization for Animal Health (OIE) launched rabies control project
to reduce rabies cases due to dog in the Philippines. Earlier in
2013, massive dog vaccination program was launched, which vaccinated
92,869 dogs and attained 80% coverage according to a press release by
World Organization for Animal Health. An article published in The
Maravi Post, Malawi also plans to vaccinate 500,000 dogs and cats to
curb the rabies crisis. Such preventive programs will help in
reducing the prevalence of the disease in lower socio-economic
classes. With developing economic conditions and consistent
government initiatives, the prevalence of rabies is expected to
shrink in the future. Higher prevalence in the Asia Pacific and
Africa provides larger customer base for players in the rabies
treatment market.
Send
An Enquiry Request @
This
research report analyzes this market on the basis of its market
segments, major geographies, and current market trends. This report
provides comprehensive analysis of
Market
growth drivers
Factors
limiting market growth
Current
market trends
Market
structure
Market
projections for upcoming years
This
report is a complete study of current trends in the market, industry
growth drivers, and restraints. It provides market projections for
the coming years. It includes analysis of recent developments in
technology, Porter’s five force model analysis and detailed
profiles of top industry players. The report also includes a review
of micro and macro factors essential for the existing market players
and new entrants along with detailed value chain analysis.
Reasons
for Buying this Report
This
report provides pin-point analysis for changing competitive dynamics
It
provides a forward looking perspective on different factors driving
or restraining market growth
It
provides a six-year forecast assessed on the basis of how the market
is predicted to grow
It
helps in understanding the key product segments and their future
It
provides pin point analysis of changing competition dynamics and
keeps you ahead of competitors
It
helps in making informed business decisions by having complete
insights of market and by making in-depth analysis of market segments
It
provides distinctive graphics and exemplified SWOT analysis of major
market segments
Check
Discount This Report From Here @
https://www.marketresearchreports.biz/sample/checkdiscount/1353555
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment